Stocksigma LogoStocksigma Logo

Beryl Drugs Submits Regulatory Filings for Quarter Ended Sep'26

Beryl Drugs Limited has submitted quarterly compliance filings to BSE for the period ended 30th Sep'26

Beryl Drugs Submits Regulatory Filings for Quarter Ended Sep'26

Beryl Drugs Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 12:14 am

Beryl Drugs Submits Regulatory Filings for Quarter Ended Sep'26 Beryl Drugs Limited has submitted quarterly compliance filings to BSE for the period ended 30th Sep'26. The company enclosed the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, alongside a non-applicability certificate under Regulation 57(5) of SEBI LODR Regulations. Beryl Drugs confirmed that Regulation 57(5) is not applicable as it has no non-convertible securities with interest, dividend, or principal obligations payable during the quarter ended 30th Sep'26.

Original exchange filing (PDF)

More announcements from Beryl Drugs Ltd

All Beryl Drugs Ltd announcements